The impact of Daratumumab on transfusion service costs-Reference-Cited by-同舟云学术

The impact of Daratumumab on transfusion service costs

Published:2019-01-08 Issue:4 Volume:59 Page:1252-1258
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Cushing Melissa M.¹^ORCID,DeSimone Robert A.¹^ORCID,Goel Ruchika¹^ORCID,Hsu Yen-Michael S.¹^ORCID,Parra Priscilla¹,Racine-Brzostek Sabrina E.¹,Degtyaryova Diana¹,Lo Dian T.¹,Morrison Meta¹,Crowley Kathleen M.¹,Rossi Adrianna²,Vasovic Ljiljana V.¹^ORCID

Affiliation:

1. Department of Pathology and Laboratory Medicine; New York-Presbyterian Hospital, Weill Cornell Medicine; New York New York

2. Department of Medicine/Division of Hematology-Oncology; New York-Presbyterian Hospital, Weill Cornell Medicine; New York New York

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.15134/fullpdf

Reference28 articles.

1. Management of relapsed and refractory multiple myeloma in modern times: incorporating new agents into decision-making;Clark;Am J Hematol,2016

2. Stability guidelines for dithiothreitol-treated red blood cell reagents used for antibody detection methods in patients treated with daratumumab;Disbro;Immunohematology,2017

3. Daratumumab, bortezomib, and dexamethasone for multiple myeloma;Palumbo;N Engl J Med,2016

4. Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis;Kaufman;Blood,2017

5. CD38 antibodies in multiple myeloma: back to the future;Donk;Blood,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia;Frontiers in Immunology;2023-01-27

2. Detection of unexpected antibodies in Korean multiple myeloma patients on daratumumab using dithiothreitol‐treated reagent cells is more efficient than extended phenotyping and genotyping;Transfusion;2022-12

3. RBC alloimmunization and daratumumab: Are efforts to eliminate interferences and prevent new antibodies necessary?;Transfusion;2021-11-12

4. Antibody incidence and red blood cell transfusions in patients on daratumumab;Transfusion;2021-10-07

5. Alloimmunisation rate of patients on Daratumumab : A retrospective cohort study of patients in England;Transfusion Medicine;2021-08-17